Stem cell patent dispute: Wisc. fights back

Written byAlison McCook

| 1 min read

In the fallout from a linkurl:major decision;http://www.the-scientist.com/news/home/53051/ by the US patent agency to reject key stem cell patents for embryonic linkurl:stem cell research;http://audio.wnyc.org/bl/bl010507d.mp3 held by the Wisconsin Alumni Research Foundation (WARF), Wisconsin Governor Jim Doyle has taken to the airwaves to defend the state's intellectual property. In a linkurl:statement;http://www.wisgov.state.wi.us/journal_media_detail.asp?locid=19&prid=2583 released yesterday (April 3), the governor reminded the public that the decision is only "preliminary," and the patents remain valid while the university goes through the appeal process. "Based on my many conversations with experts in the field over the past few years, I am confident that these patents will ultimately be upheld," Doyle said. WARF Managing Director Carl Gulbrandsen appears equally confident, if not more so, that the patents will prevail. When groups linkurl:first challenged;http://www.the-scientist.com/news/display/25037/ the patents, he called their case "ludicrous" in an interview with The Scientist. In a statement released by WARF following this week's decision, Gulbrandsen said it was "inconceivable" that the research performed by Wisconsin biologist James Thomson was not worthy of a patent. Financially, WARF has fared quite well -- in 2005-2006, the organization linkurl:funded;http://www.warf.org/about/index.jsp?cid=27&scid=36 $65 million worth of research at the University of Wisconsin. You can share your thoughts about WARF's odds of reversing the US Patent and Trademark Office's decision here.

Stem cell patent dispute: Wisc. fights back

The Scientist ARCHIVES

Become a Member of

Meet the Author

Alison McCook

Related Research Resources

A Stubborn Gene, a Failed Experiment, and a New Path

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Advancing Drug Discovery with Complex Human In Vitro Models

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Maximizing Cancer Research Model Systems

Products

Product News

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies